相关实验视频

Updated: Sep 13, 2025

A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice

A Behavioral Test Battery for the Repeated Assessment of Motor Skills, Mood, and Cognition in Mice

Published on: March 2, 2019

帕金森病的轻度行为障碍检查清单:认知评估中的辅助工具

Gabriel D Pinilla-Monsalve^1,2, Yuan P Song^1,3, Alexandru Hanganu^1,3

¹Centre de recherche de l'Institut universitaire de gériatrie de Montréal, Montreal, Quebec, Canada.

Movement disorders clinical practice

|August 4, 2025

概括

一个修订的轻度行为障碍检查清单 (MBI-C) 显示了用于识别帕金森病 (PD) 中神经精神病症状的改善心理测量特性. 这个经过验证的工具有助于检测PD患者的认知障碍风险.

科学领域:

神经科学是一个神经科学.
临床心理学临床心理学
老年学是一门学科.

背景情况:

轻度行为障碍 (MBI) 在晚年呈现为神经精神症状 (NPS),可能表明痴呆症.
在帕金森病 (PD) 中,MBI与认知衰退,大脑变化和改变的连接性相关.
MBI检查清单 (MBI-C) 评估了神经退行风险的持续行为变化,但需要在PD中进行验证.

研究的目的:

在加拿大PD队列中验证MBI-C的心理特征.
开发和提出一个经过修订的MBI-C,优化PD评估.
评估修订后的MBI-C在确定PD认知障碍方面的实用性.

主要方法:

在MBI-C中,来自加拿大开放帕金森网络的406名PD患者接受了MBI-C.
使用探索性因子分析评估了构造有效性.
与 MDS-UPDRS,NPI 和 MoCA 相比,同时和标准的有效性得到了检查.

主要成果:

最初的34项MBI-C具有显著的底部效应 (24.9%).
一个24项,5因素的MBI-C显示出良好的内部一致性 (Cronbach的α=0.856).
修订后的MBI-C与NPI (ICC = 0.633) 显示了适度的并发有效性,认知障碍的截止分数为6.7.

结论:

修订后的MBI-C为PD的MBI评估提供了更好的心理测量性能.
修订后的检查清单显示了认知障碍的可接受特异性.
未来的研究应该探索微妙的MBI表现,患者护理人员协议和认知衰退的预测有效性.

关键词:

帕金森病的疾病.轻度行为障碍轻度行为障碍轻度的认知障碍轻度的认知障碍心理测量是指心理测量.

更多相关视频

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...